Effect of nucleic acid amplification testing on population-based incidence rates of clostridium difficile infection

Carolyn V. Gould, Jonathan R. Edwards, Jessica Cohen, Wendy M. Bamberg, Leigh Ann Clark, Monica M. Farley, Helen Johnston, Joelle Nadle, Lisa Winston, Dale N. Gerding, L. Clifford McDonald, Fernanda C. Lessa, Zintars Beldavs, Samir Hanna, Gary Hollick, Stacy Holzbauer, Carol Lyons, Erin Phipps, Lucy Wilson

Research output: Contribution to journalArticle

Abstract

Nucleic acid amplification testing (NAAT) is increasingly being adopted for diagnosis of Clostridium difficile infection (CDI). Data from 3 states conducting population-based CDI surveillance showed increases ranging from 43% to 67% in CDI incidence attributable to changing from toxin enzyme immunoassays to NAAT. CDI surveillance requires adjustment for testing methods.

Original languageEnglish (US)
Pages (from-to)1304-1307
Number of pages4
JournalClinical Infectious Diseases
Volume57
Issue number9
DOIs
StatePublished - Nov 1 2013

Fingerprint

Clostridium Infections
Clostridium difficile
Nucleic Acids
Incidence
Population
Immunoenzyme Techniques

Keywords

  • clinical laboratory techniques
  • Clostridium difficile
  • incidence
  • nucleic acid amplification techniques
  • surveillance

ASJC Scopus subject areas

  • Infectious Diseases
  • Microbiology (medical)

Cite this

Gould, C. V., Edwards, J. R., Cohen, J., Bamberg, W. M., Clark, L. A., Farley, M. M., ... Wilson, L. (2013). Effect of nucleic acid amplification testing on population-based incidence rates of clostridium difficile infection. Clinical Infectious Diseases, 57(9), 1304-1307. https://doi.org/10.1093/cid/cit492

Effect of nucleic acid amplification testing on population-based incidence rates of clostridium difficile infection. / Gould, Carolyn V.; Edwards, Jonathan R.; Cohen, Jessica; Bamberg, Wendy M.; Clark, Leigh Ann; Farley, Monica M.; Johnston, Helen; Nadle, Joelle; Winston, Lisa; Gerding, Dale N.; McDonald, L. Clifford; Lessa, Fernanda C.; Beldavs, Zintars; Hanna, Samir; Hollick, Gary; Holzbauer, Stacy; Lyons, Carol; Phipps, Erin; Wilson, Lucy.

In: Clinical Infectious Diseases, Vol. 57, No. 9, 01.11.2013, p. 1304-1307.

Research output: Contribution to journalArticle

Gould, CV, Edwards, JR, Cohen, J, Bamberg, WM, Clark, LA, Farley, MM, Johnston, H, Nadle, J, Winston, L, Gerding, DN, McDonald, LC, Lessa, FC, Beldavs, Z, Hanna, S, Hollick, G, Holzbauer, S, Lyons, C, Phipps, E & Wilson, L 2013, 'Effect of nucleic acid amplification testing on population-based incidence rates of clostridium difficile infection', Clinical Infectious Diseases, vol. 57, no. 9, pp. 1304-1307. https://doi.org/10.1093/cid/cit492
Gould, Carolyn V. ; Edwards, Jonathan R. ; Cohen, Jessica ; Bamberg, Wendy M. ; Clark, Leigh Ann ; Farley, Monica M. ; Johnston, Helen ; Nadle, Joelle ; Winston, Lisa ; Gerding, Dale N. ; McDonald, L. Clifford ; Lessa, Fernanda C. ; Beldavs, Zintars ; Hanna, Samir ; Hollick, Gary ; Holzbauer, Stacy ; Lyons, Carol ; Phipps, Erin ; Wilson, Lucy. / Effect of nucleic acid amplification testing on population-based incidence rates of clostridium difficile infection. In: Clinical Infectious Diseases. 2013 ; Vol. 57, No. 9. pp. 1304-1307.
@article{e81796a75c184e2d906430517f79f806,
title = "Effect of nucleic acid amplification testing on population-based incidence rates of clostridium difficile infection",
abstract = "Nucleic acid amplification testing (NAAT) is increasingly being adopted for diagnosis of Clostridium difficile infection (CDI). Data from 3 states conducting population-based CDI surveillance showed increases ranging from 43{\%} to 67{\%} in CDI incidence attributable to changing from toxin enzyme immunoassays to NAAT. CDI surveillance requires adjustment for testing methods.",
keywords = "clinical laboratory techniques, Clostridium difficile, incidence, nucleic acid amplification techniques, surveillance",
author = "Gould, {Carolyn V.} and Edwards, {Jonathan R.} and Jessica Cohen and Bamberg, {Wendy M.} and Clark, {Leigh Ann} and Farley, {Monica M.} and Helen Johnston and Joelle Nadle and Lisa Winston and Gerding, {Dale N.} and McDonald, {L. Clifford} and Lessa, {Fernanda C.} and Zintars Beldavs and Samir Hanna and Gary Hollick and Stacy Holzbauer and Carol Lyons and Erin Phipps and Lucy Wilson",
year = "2013",
month = "11",
day = "1",
doi = "10.1093/cid/cit492",
language = "English (US)",
volume = "57",
pages = "1304--1307",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "9",

}

TY - JOUR

T1 - Effect of nucleic acid amplification testing on population-based incidence rates of clostridium difficile infection

AU - Gould, Carolyn V.

AU - Edwards, Jonathan R.

AU - Cohen, Jessica

AU - Bamberg, Wendy M.

AU - Clark, Leigh Ann

AU - Farley, Monica M.

AU - Johnston, Helen

AU - Nadle, Joelle

AU - Winston, Lisa

AU - Gerding, Dale N.

AU - McDonald, L. Clifford

AU - Lessa, Fernanda C.

AU - Beldavs, Zintars

AU - Hanna, Samir

AU - Hollick, Gary

AU - Holzbauer, Stacy

AU - Lyons, Carol

AU - Phipps, Erin

AU - Wilson, Lucy

PY - 2013/11/1

Y1 - 2013/11/1

N2 - Nucleic acid amplification testing (NAAT) is increasingly being adopted for diagnosis of Clostridium difficile infection (CDI). Data from 3 states conducting population-based CDI surveillance showed increases ranging from 43% to 67% in CDI incidence attributable to changing from toxin enzyme immunoassays to NAAT. CDI surveillance requires adjustment for testing methods.

AB - Nucleic acid amplification testing (NAAT) is increasingly being adopted for diagnosis of Clostridium difficile infection (CDI). Data from 3 states conducting population-based CDI surveillance showed increases ranging from 43% to 67% in CDI incidence attributable to changing from toxin enzyme immunoassays to NAAT. CDI surveillance requires adjustment for testing methods.

KW - clinical laboratory techniques

KW - Clostridium difficile

KW - incidence

KW - nucleic acid amplification techniques

KW - surveillance

UR - http://www.scopus.com/inward/record.url?scp=84886873052&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886873052&partnerID=8YFLogxK

U2 - 10.1093/cid/cit492

DO - 10.1093/cid/cit492

M3 - Article

C2 - 23899677

AN - SCOPUS:84886873052

VL - 57

SP - 1304

EP - 1307

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 9

ER -